FCA
CVS icon

FinTrust Capital Advisors’s CVS Health CVS Stock Holding History

FinTrust Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$611K Sell
9,713
-1,897
-16% -$111K 0.1% 165
2024
Q2 		$686K Sell
11,610
-4,462
-28% -$279K 0.12% 144
2024
Q1 		$1.28M Sell
16,072
-670
-4% -$51.2K 0.25% 87
2023
Q4 		$1.32M Sell
16,742
-797
-5% -$56.7K 0.26% 79
2023
Q3 		$1.22M Buy
17,539
+365
+2% +$25.9K 0.27% 82
2023
Q2 		$1.6M Hold
17,174
– – 0.38% 66
2023
Q1 		$1.6M Hold
17,174
– – 0.39% 65
2022
Q4 		$1.6M Sell
17,174
-2,270
-12% -$219K 0.39% 67
2022
Q3 		$1.79M Buy
19,444
+949
+5% +$93.9K 0.46% 48
2022
Q2 		$1.74M Buy
18,495
+1,353
+8% +$132K 0.44% 55
2022
Q1 		$1.73M Buy
17,142
+2,627
+18% +$276K 0.4% 61
2021
Q4 		$1.5M Buy
14,515
+1,386
+11% +$128K 0.36% 63
2021
Q3 		$1.11M Buy
13,129
+1,688
+15% +$141K 0.29% 74
2021
Q2 		$955K Buy
11,441
+1,058
+10% +$86.6K 0.25% 84
2021
Q1 		$781K Buy
10,383
+644
+7% +$46.9K 0.23% 91
2020
Q4 		$665K Buy
9,739
+899
+10% +$58.5K 0.21% 94
2020
Q3 		$516 Sell
8,840
-16,135
-65% -$1M 0.1% 111
2020
Q2 		$1.62M Buy
24,975
+9,800
+65% +$617K 0.64% 42
2020
Q1 		$900K Buy
15,175
+1,865
+14% +$125K 0.44% 44
2019
Q4 		$989K Buy
13,310
+6,039
+83% +$424K 0.4% 46
2019
Q3 		$459K Sell
7,271
-332
-4% -$19.7K 0.16% 129
2019
Q2 		$414K Buy
7,603
+34
+0.4% +$1.83K 0.17% 124
2019
Q1 		$408K Buy
7,569
+841
+13% +$51.9K 0.17% 119
2018
Q4 		$441K Buy
+6,728
New +$502K 0.22% 101

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

FinTrust Capital Advisors's CVS Position: Q3 2024 in Review

FinTrust Capital Advisors reduced its CVS Health (CVS) stake by 16% in Q3 2024, selling an estimated $111K and leaving 9,713 shares worth $611K. The position accounts for 0.1% of the portfolio, ranked #165.

FinTrust Capital Advisors first reported a position in CVS in Q4 2018 and has held it in 24 quarters since. The position peaked at $1.79M in Q3 2022. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • FinTrust Capital Advisors held 9,713 shares of CVS Health worth $611K as of Q3 2024.
  • FinTrust Capital Advisors sold 1,897 CVS Health shares in Q3 2024, an estimated $111K.
  • CVS Health made up 0.1% of FinTrust Capital Advisors's portfolio in Q3 2024, its #165 holding.
  • FinTrust Capital Advisors first reported a position in CVS Health in Q4 2018 and has held it in 24 quarters since.
  • FinTrust Capital Advisors's CVS Health position peaked at $1.79M in Q3 2022.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.